Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours Β· Estimated delivery Aug 31 - Sep 5
the Yellow Card scheme applies to licensed medicines, not investigational products
La concentracin final se determina por el volumen de diluyente en relacin con los miligramos del vial, lo que permite dosificar volmenes pequeos y reproducibles dado el carcter potente y acumulativo del compuesto
A higher concentration means smaller volumes per dose
North America Glucagon-like Peptide-1 Agonists Top Companies AstraZeneca Sanofi Eli Lilly and Company Pfizer Novo Nordisk *Disclaimer: Top companies sorted in no particular order North America Glucagon-like Peptide-1 Agonists Market Concentration North America Glucagon-like Peptide-1 Agonists Company List Adocia SA Amgen AstraZeneca Boehringer Ingelheim Biocon Ltd Eli Lilly and Company Hanmi Pharmaceutical Co
US$ 19.99
US$ 25.41
US$ 24.78
